Immunitybio | search
Click here to view Immunitybio news from 60+ newspapers.
Bookmark or Share- Immunotherapy by ImmunityBio - Cancer Vaccine ResearchImmunityBio’s platforms address the entire immune system, harnessing the power of both innate and adaptive functions of the immune system by activation of ‘first responder’ natural killer (NK) cells, T cells, and macrophages, and establishment of immune memory by dendritic cells.
- Immunotherapy Clinical Trials Pipeline - ImmunityBioExplore ImmunityBio's pipeline to find information on our clinical trials. We have immunotherapy trials in various stages focusing on a variety of diseases.
- Pharmaceutical Biotechnology & Clinical Research Jobs - ImmunityBioImmunityBio is continuously pursuing new immunotherapies designed to attack disease by enhancing the patient’s immune system, not weakening it.
- Investor Relations - ImmunityBio, Inc.ImmunityBio is a vertically-integrated biotechnology company developing next-generation therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. The company’s range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of ...
- Latest News in Targeted Cell Therapies for Cancer ... - ImmunityBioImmunityBio’s platform addresses the entire immune system beyond the limitations of chimeric antigen receptor T-cell (CAR-T) therapies and checkpoint inhibitors by activating the natural killer cell, T cells, macrophages, and inducing memory through dendritic cells.
More
